Corrigendum: Identification of novel anti-amoebic pharmacophores from kinase inhibitor chemotypes (Frontiers in Microbiology, (2023), 14, (1149145), 10.3389/fmicb.2023.1149145)

Abstract

In the published article, there was an error in the author list, and author “Claudia Gómez-Liñán” was erroneously excluded. The corrected author list appears below. Lori Ferrins1*, Melissa J. Buskes1, Madison M. Kapteyn2, Hannah N. Engels2, Suzanne E. Enos2,3, Chenyang Lu4, Dana M. Klug1, Baljinder Singh1, Antonio Quotadamo1,5, Kelly Bachovchin1, Westley F. Tear1, Andrew E. Spaulding1, Katherine C. Forbes1, Seema Bag1, Mitch Rivers1, Catherine LeBlanc1, Erin Burchfield1, Jeremy R. Armand1, Rosario Diaz-Gonzalez6, Gloria Ceballos-Perez6, Raquel García-Hernández6, Guiomar Pérez-Moreno6, Cristina Bosch-Navarrete6, Claudia Gómez-Liñán6, Luis Miguel Ruiz-Pérez6, Francisco Gamarro6, Dolores González-Pacanowska6, Miguel Navarro6, Kojo Mensa-Wilmot7, Michael P. Pollastri1, Dennis E. Kyle2 and Christopher A. Rice2,3,4*† In the original article there was also an error in the Author Contribution section. The correct author contributions section appears below: CR, MB, and LF: conceptualization. LF, MB, MK, HE, SE, CLu, DKl, BS, AQ, KB, WT, AS, KF, SB, MR, CLe, EB, JA, RD-G, GC-P, GP-M, CB-N, CG-L, DG-P, MN, and CR: methodology. CR, DKy, MP, and LF: validation and supervision. LF and CR: formal analysis and writing—original draft preparation. DKy, MP, and LF: resources and funding acquisition. LF, MB, DKl, BS, KB, WT, SB, MK, HE, SE, CLu, CB-N, and CR: data curation. LF, MB, MK, HE, SE, CLu, DKl, BS, AQ, KB, WT, AS, KF, SB, MR, CLe, EB, JA, RD-G, GC-P, RG-H, GP-M, CB-N, CG-L, LR-P, FG, DG-P, MN, KM-W, MP, DKy, and CR: writing—review and editing. All authors contributed to the article and approved the submitted version. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.